Australian health cost savings through complementary medicine use as of 2014

This report, published by the Australian Self Medication Industry (ASMI), presents a study done by Frost & Sullivan on the potential health outcomes and cost savings of select complementary medicines in Australia. The report includes the following disease conditions: osteoporosis or osteopenia, cardiovascular disease (CVD), age-related macular degeneration (AMD), and moderate major depression; and looks at the impact of complementary medicines such as calcium and vitamin D, magnesium, omega-3 fatty acids, and folic acid B6 and B12 on these disease conditions.
  • Language: English
  • Released: October 2014
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!